Cargando…
Identifying Individual Medications Affecting Pulmonary Outcomes When Multiple Medications are Present
Autores principales: | Li, Yisha, Dai, Ran, Gwon, Yeongjin, Rennard, Stephen I, Make, Barry J, Foer, Dinah, Strand, Matthew J, Austin, Erin, Young, Kendra A, Hokanson, John E, Pratte, Katherine A, Conway, Rebecca, Kinney, Gregory L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9167843/ https://www.ncbi.nlm.nih.gov/pubmed/35677475 http://dx.doi.org/10.2147/CLEP.S364692 |
Ejemplares similares
-
Co-Morbidity Patterns Identified Using Latent Class Analysis of Medications Predict All-Cause Mortality Independent of Other Known Risk Factors: The COPDGene(®) Study
por: Li, Yisha, et al.
Publicado: (2020) -
Longitudinal Assessment of Multimorbidity Medication Patterns among Smokers in the COPDGene Cohort
por: Li, Yisha, et al.
Publicado: (2023) -
Comment on Albogami et al. Glucagon-Like Peptide 1 Receptor Agonists and Chronic Lower Respiratory Disease Exacerbations Among Patients With Type 2 Diabetes. Diabetes Care 2021;44:1344–1352
por: Foer, Dinah, et al.
Publicado: (2021) -
Utility of Hypoglycemic Agents to Treat Asthma with Comorbid Obesity
por: Ge, Derek, et al.
Publicado: (2022) -
Pulmonary Function Reduction in Diabetes With and Without Chronic Obstructive Pulmonary Disease
por: Kinney, Gregory L., et al.
Publicado: (2014)